This inventor holds 1 USPTO granted patent. Top assignee: National Defense Medical Center. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Mind of Yu-Chi Lin: Advancements in Nucleic Acid Technologies
Introduction: Yu-Chi Lin, an esteemed inventor based in Hsindian, Taiwan, has made significant contributions to the field of biotechnology. With a focus on nucleic acid molecules and polypeptides, Lin's work has the potential to impact medical research and therapeutic applications significantly.
Latest Patents: Yu-Chi Lin is credited with one prominent patent that discloses nucleic acid molecules and a novel protein related to h-ADAM7, known as GP-83. This invention encompasses a variety of components including the purified GP-83 protein, fusion proteins, antigenic peptides, and anti-GP-83 antibodies. Additionally, it includes isolated GP-83 nucleic acid molecules, recombinant vectors containing these nucleic acids, host cells with the recombinant vectors, and non-human transgenic animals into which the GP-83 nucleic acid molecule has been introduced or interrupted.
Career Highlights: Lin is currently associated with the National Defense Medical Center, where he applies his expertise in biomedicine. His position at such a premier institution has allowed him to work at the intersection of healthcare and technological advancement, pushing the boundaries of innovation in the field.
Collaborations: Throughout his career, Yu-Chi Lin has collaborated with prominent colleagues, including Hwan-Wun Liu and Guang-Huan Sun. These collaborations have fostered an environment of shared knowledge and innovation, enabling them to tackle complex problems in biotechnology collectively.
Conclusion: Yu-Chi Lin’s innovative work in nucleic acid technologies represents a significant stride in the scientific community. His contributions not only reflect his expertise but also inspire future research aimed at harnessing the potential of biotechnology for medical advancements. With the foundation laid by Lin and his peers, we can anticipate further breakthroughs that may enhance the quality of healthcare and our understanding of biological mechanisms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile